Application 021375
- Type
- NDA
- Sponsor
- GLAXOSMITHKLINE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ALAVERT | LORATADINE | TABLET, ORALLY DISINTEGRATING;ORAL | 10MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021375-001 | ALAVERT | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alavert Allergy | LORATADINE | Foundation Consumer Brands | 039ea563-9796-4270-b84a-50dd25a9d976 | 2026-02-23 | Warnings | 021375 NDA021375 80070-120 |
| Alavert Allergy | LORATADINE | Foundation Consumer Brands | f741d1cf-0ecb-4405-8596-07af394537db | 2026-02-23 | Warnings | 021375 NDA021375 80070-110 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0573-2620 | ALAVERT ALLERGY | loratadine | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0573-2620 | ALAVERT ALLERGY | loratadine | Wyeth Consumer Healthcare LLC | NDA | Current |
| 0573-2620 | ALAVERT ALLERGY | loratadine | Wyeth Consumer Healthcare LLC | NDA | Current |
| 0573-2621 | ALAVERT ALLERGY | loratadine | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0573-2621 | ALAVERT ALLERGY | loratadine | Wyeth Consumer Healthcare LLC | NDA | Current |
| 0573-2621 | ALAVERT ALLERGY | loratadine | Wyeth Consumer Healthcare LLC | NDA | Current |
| 80070-110 | Alavert | LORATADINE | Foundation Consumer Brands | NDA | Current |
| 80070-120 | Alavert | LORATADINE | Foundation Consumer Brands | NDA | Current |